Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shaojun Shi

Showing results (21-30 of 75) with videos related to

Pageof 8
Sort By:
Plos One|February 4, 2016
Association of RAC1 Gene Polymorphisms with Primary End-Stage Renal Disease in Chinese Renal RecipientsYani Liu, Jiali Zhou, Xiaomei Luo, et al.
Basic & Clinical Pharmacology & Toxicology|July 21, 2011
Safety, tolerability, pharmacokinetics and pharmacodynamics of recombinant human parathyroid hormone after single- and multiple-dose subcutaneous administration in healthy Chinese volunteersYani Liu, Shaojun Shi, Jianhong Wu, et al.
Clinical Therapeutics|January 4, 2011
Pharmacokinetics and tolerability of intravenous cefotetan disodium for injection in healthy Chinese volunteers: A randomized, open-label, single- and multiple-dose studyShaojun Shi, Yani Liu, Zhongfang Li, et al.
Molecular Medicine Reports|August 12, 2016
Impact of quercetin‑induced changes in drug‑metabolizing enzyme and transporter expression on the pharmacokinetics of cyclosporine in ratsYani Liu, Xiaomei Luo, Chunxiao Yang, et al.
Journal of Clinical Pharmacology|October 2, 2007
Single- and multiple-dose pharmacokinetics of pirfenidone, an antifibrotic agent, in healthy Chinese volunteersShaojun Shi, Jianhong Wu, Huating Chen, et al.
International Immunopharmacology|November 18, 2023
Intracellular tacrolimus concentration correlates with impaired renal function through regulation of the IS-AHR-ABC transporter in peripheral blood mononuclear cellsPengpeng Guo, Rui Zhang, Jinping Zhou, et al.
European Journal of Drug Metabolism and Pharmacokinetics|January 23, 2016
Tolerability and Pharmacokinetics of Hydronidone, an Antifibrotic Agent for Hepatic Fibrosis, after Single and Multiple Doses in Healthy Subjects: an Open-Label, Randomized, Dose-Escalating, First-in-Human StudyYani Liu, Jianhong Wu, Zhongfang Li, et al.
Gut Microbes|February 9, 2024
Vancomycin relieves tacrolimus-induced hyperglycemia by eliminating gut bacterial beta-glucuronidase enzyme activityPeixia Li, Rui Zhang, Jinping Zhou, et al.
Computational and Mathematical Methods in Medicine|February 16, 2022
The Value of Echocardiography Combined with NT-pro BNP Level in Assessment and Prognosis of Diastolic Heart FailureShaolei Chen, Yanli Zhou, Xia Wu, et al.
Analytical Biochemistry|August 7, 2022
A novel, simple and reliable method for the determination of hydronidone and its metabolites M3 and M4 in human plasma and urine by HPLC-MS/MS and its application to a pharmacokinetic study in health Chinese subjectsRui Zhang, Peixia Li, Jinping Zhou, et al.
Pageof 8

Showing results (21-30 of 75) with videos related to

Sort By:
Pageof 8
Plos One|February 4, 2016
Association of RAC1 Gene Polymorphisms with Primary End-Stage Renal Disease in Chinese Renal RecipientsYani Liu, Jiali Zhou, Xiaomei Luo, et al.
Basic & Clinical Pharmacology & Toxicology|July 21, 2011
Safety, tolerability, pharmacokinetics and pharmacodynamics of recombinant human parathyroid hormone after single- and multiple-dose subcutaneous administration in healthy Chinese volunteersYani Liu, Shaojun Shi, Jianhong Wu, et al.
Clinical Therapeutics|January 4, 2011
Pharmacokinetics and tolerability of intravenous cefotetan disodium for injection in healthy Chinese volunteers: A randomized, open-label, single- and multiple-dose studyShaojun Shi, Yani Liu, Zhongfang Li, et al.
Molecular Medicine Reports|August 12, 2016
Impact of quercetin‑induced changes in drug‑metabolizing enzyme and transporter expression on the pharmacokinetics of cyclosporine in ratsYani Liu, Xiaomei Luo, Chunxiao Yang, et al.
Journal of Clinical Pharmacology|October 2, 2007
Single- and multiple-dose pharmacokinetics of pirfenidone, an antifibrotic agent, in healthy Chinese volunteersShaojun Shi, Jianhong Wu, Huating Chen, et al.
International Immunopharmacology|November 18, 2023
Intracellular tacrolimus concentration correlates with impaired renal function through regulation of the IS-AHR-ABC transporter in peripheral blood mononuclear cellsPengpeng Guo, Rui Zhang, Jinping Zhou, et al.
European Journal of Drug Metabolism and Pharmacokinetics|January 23, 2016
Tolerability and Pharmacokinetics of Hydronidone, an Antifibrotic Agent for Hepatic Fibrosis, after Single and Multiple Doses in Healthy Subjects: an Open-Label, Randomized, Dose-Escalating, First-in-Human StudyYani Liu, Jianhong Wu, Zhongfang Li, et al.
Gut Microbes|February 9, 2024
Vancomycin relieves tacrolimus-induced hyperglycemia by eliminating gut bacterial beta-glucuronidase enzyme activityPeixia Li, Rui Zhang, Jinping Zhou, et al.
Computational and Mathematical Methods in Medicine|February 16, 2022
The Value of Echocardiography Combined with NT-pro BNP Level in Assessment and Prognosis of Diastolic Heart FailureShaolei Chen, Yanli Zhou, Xia Wu, et al.
Analytical Biochemistry|August 7, 2022
A novel, simple and reliable method for the determination of hydronidone and its metabolites M3 and M4 in human plasma and urine by HPLC-MS/MS and its application to a pharmacokinetic study in health Chinese subjectsRui Zhang, Peixia Li, Jinping Zhou, et al.
Pageof 8